Clinical Features and Analysis in Pituitary Stalk Interruption Syndrome

Table 3

Biochemical features in 24 PSIS patients.

Parameters	Results	Normal range
ALT (U/L)	46.13 ± 37.3	1–40
AST (U/L)	48.63 ± 35.38	1–37
ALP (U/L)	164.7 ± 41.21	0–110
Blood albumin (g/L)	45.8 ± 2.52	35–50
Total bilirubin (μmol/L)	12.78 ± 4.84	3–22
TC (mmol/L)	5.75 ± 1.19	3.1–5.2
TG (mmol/L)	1.79 ± 0.98	0.33–1.7
LDL-C (mmol/L)	3.87 ± 0.97	1.94–3.40
HDL-C (mmol/L)	1.09 ± 0.28	1.09–1.63
FBG (mmol/L)	5.05 ± 1.15	2.9–6.0
Creatinine (umol/L)	60.79 ± 12.85	53–115
Urea nitrogen (mmol/L)	4.54 ± 1.29	2.9–8.6
Uric acid (μmol/L)	427.45 ± 125.93	200–420
Serum calcium (mmol/L)	2.39 ± 0.11	2.1–2.6
Serum phosphorus (mmol/L)	1.45 ± 0.27	0.97–1.62
Serum sodium (mmol/L)	139.21 ± 2.23	135–145
Serum potassium (mmol/L)	4.05 ± 0.31	3.5–5.3
Dyslipidemia, n (%)	19 (79.2%)
NAFLD, n (%)	15 (62.5%)
Hyperuricemia, n (%)	9 (37.5%)

Data are expressed as mean ± standard deviation, median (interquartile range), and numbers (percentage). ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; FPG, fasting plasma glucose; NAFLD, nonalcoholic fatty liver disease.